![Teva launches first DTC for Austedo into competitive tardive dyskinesia 2-drug market | Fierce Pharma Teva launches first DTC for Austedo into competitive tardive dyskinesia 2-drug market | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1622184941/CampaignImage.jpg?VersionId=gHnBXNNfFLK.Ce1UZv0iQmF7Ue01jwSd)
Teva launches first DTC for Austedo into competitive tardive dyskinesia 2-drug market | Fierce Pharma
![Teva Launches 'It's Not OK - It's TD' National Television Advertising Campaign to Increase Awareness of Tardive Dyskinesia and AUSTEDO® (deutetrabenazine) tablets Teva Launches 'It's Not OK - It's TD' National Television Advertising Campaign to Increase Awareness of Tardive Dyskinesia and AUSTEDO® (deutetrabenazine) tablets](https://mma.prnewswire.com/media/1510758/Teva_Logo.jpg?p=facebook)
Teva Launches 'It's Not OK - It's TD' National Television Advertising Campaign to Increase Awareness of Tardive Dyskinesia and AUSTEDO® (deutetrabenazine) tablets
![Yo-Bio on Twitter: "$TEVA #Austedo have no black box warning for tardive dyskinesia. Only for HD (Read about HD and you will understand way). $NBIX #INGREZZA https://t.co/lXnoHCEUAA" / Twitter Yo-Bio on Twitter: "$TEVA #Austedo have no black box warning for tardive dyskinesia. Only for HD (Read about HD and you will understand way). $NBIX #INGREZZA https://t.co/lXnoHCEUAA" / Twitter](https://pbs.twimg.com/media/DIixM-gWsAEY-6O.jpg:large)
Yo-Bio on Twitter: "$TEVA #Austedo have no black box warning for tardive dyskinesia. Only for HD (Read about HD and you will understand way). $NBIX #INGREZZA https://t.co/lXnoHCEUAA" / Twitter
![Punit on Twitter: "Teva hiked the price of #Austedo by ~6% in Jan.2021 Cost of treatment in US~ $60,000 a yr/patient 9MFY20 sales~ $451M (up 64% vs 2019) Tardive dyskinesia affects~ 500,000 Punit on Twitter: "Teva hiked the price of #Austedo by ~6% in Jan.2021 Cost of treatment in US~ $60,000 a yr/patient 9MFY20 sales~ $451M (up 64% vs 2019) Tardive dyskinesia affects~ 500,000](https://pbs.twimg.com/media/EtcRdfzXUAAIsET.jpg:large)
Punit on Twitter: "Teva hiked the price of #Austedo by ~6% in Jan.2021 Cost of treatment in US~ $60,000 a yr/patient 9MFY20 sales~ $451M (up 64% vs 2019) Tardive dyskinesia affects~ 500,000
![Teva announces FDA approval of Austedo tablets for chorea associated with huntington's disease - Pharma Advancement Teva announces FDA approval of Austedo tablets for chorea associated with huntington's disease - Pharma Advancement](https://www.pharmaadvancement.com/wp-content/uploads/2017/04/teva_pharma.jpg)
Teva announces FDA approval of Austedo tablets for chorea associated with huntington's disease - Pharma Advancement
![Austedo for Huntington's disease: Teva Pharmaceuticals has found a nifty way to keep drugs in your body for longer — Quartz Austedo for Huntington's disease: Teva Pharmaceuticals has found a nifty way to keep drugs in your body for longer — Quartz](https://cms.qz.com/wp-content/uploads/2017/04/rtx15k2q.jpg?quality=75&strip=all&w=410&h=231)
Austedo for Huntington's disease: Teva Pharmaceuticals has found a nifty way to keep drugs in your body for longer — Quartz
![Teva Announces FDA Approval of AUSTEDO™ (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington's Disease Teva Announces FDA Approval of AUSTEDO™ (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington's Disease](https://orangecounty.hdsa.org/upload/tevaneuro-809551492541210.jpg)